Trastuzumab emtansine (Kadcyla)

Item Medicine
Brand name Kadcyla
Generic name Trastuzumab emtansine
Final report date 03/07/2018
Target population HER2-positive, unresectable locally advanced or metastatic breast cancer
Comparator Chemotherapy only
ICER JPY 10 million/QALY and over